Learn more about the McMaster researchers behind ground-breaking infectious disease research.
Immunologist and vaccine researcher Zhou Xing explains how he and a large team of colleagues mobilized 20 years of vaccine research to rapidly develop and test two new second-generation COVID-19 vaccine candidates.
The Robert E. Fitzhenry Vector Laboratory is the first facility of its kind in Canada and one of a few with the capacity to develop and produce viral-vectored vaccines for clinical testing.
McMaster logo
McMaster logo
